Explore more publications!
Healthcare Times of Nebraska
Got News to Share?

Healthcare Times of Nebraska: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times of Nebraska.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on April 23, 2026

Cook County Health Recognizes 60th Anniversary of Trauma Unit
Apr. 23, 2026

Cook County Health Recognizes 60th Anniversary of Trauma Unit

Indeterminate GlobeNewswire
Hormify Launches Transparent, Research-Based Supplement for Hormonal Balance and Daily Wellness
Apr. 23, 2026

Hormify Launches Transparent, Research-Based Supplement for Hormonal Balance and Daily Wellness

Indeterminate GlobeNewswire
AI-Powered Nerve Monitoring Systems Poised to Transform Surgical Safety as Workforce Shortages Drive Remote Monitoring Adoption
Apr. 23, 2026

AI-Powered Nerve Monitoring Systems Poised to Transform Surgical Safety as Workforce Shortages Drive Remote Monitoring Adoption

Indeterminate GlobeNewswire
Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report
Apr. 23, 2026

Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report

Indeterminate GlobeNewswire
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
Apr. 23, 2026

Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104

Indeterminate GlobeNewswire
Otarmeni™ (lunsotogene parvec-cwha) Approved by FDA as First and Only Gene Therapy for Genetic Hearing Loss; Regeneron to Provide Otarmeni for Free in the U.S.
Apr. 23, 2026

Otarmeni™ (lunsotogene parvec-cwha) Approved by FDA as First and Only Gene Therapy for Genetic Hearing Loss; Regeneron to Provide Otarmeni for Free in the U.S.

Indeterminate GlobeNewswire
PridCor Therapeutics Secures Global Antiviral Portfolio, Establishing Leadership in Treatment of Long COVID and Infection-Associated Chronic Illnesses
Apr. 23, 2026

PridCor Therapeutics Secures Global Antiviral Portfolio, Establishing Leadership in Treatment of Long COVID and Infection-Associated Chronic Illnesses

Indeterminate GlobeNewswire
Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
Apr. 23, 2026

Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026

Indeterminate GlobeNewswire
Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm Society Meeting
Apr. 23, 2026

Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm Society Meeting

Indeterminate GlobeNewswire
Chiffre d’affaires du 1er trimestre 2026
Apr. 23, 2026

Chiffre d’affaires du 1er trimestre 2026

Indeterminate GlobeNewswire
Q1 2026 revenue
Apr. 23, 2026

Q1 2026 revenue

Indeterminate GlobeNewswire
FSR, in Partnership with ATS, Welcomes Dr. Matt Craig to Drive Strategic Research Initiatives
Apr. 23, 2026

FSR, in Partnership with ATS, Welcomes Dr. Matt Craig to Drive Strategic Research Initiatives

Indeterminate GlobeNewswire
New Data Quantifies the "NASM Premium": Certified Professionals Earn 22% More Than Industry Peers
Apr. 23, 2026

New Data Quantifies the "NASM Premium": Certified Professionals Earn 22% More Than Industry Peers

Indeterminate GlobeNewswire
Mother’s Day Gift Ideas for Moms: Experiential Gifts Like Cooking Together Trending in 2026
Apr. 23, 2026

Mother’s Day Gift Ideas for Moms: Experiential Gifts Like Cooking Together Trending in 2026

Indeterminate GlobeNewswire
The Center for Cancer and Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating first community oncology patient in Maryland-area clinic
Apr. 23, 2026

The Center for Cancer and Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating first community oncology patient in Maryland-area clinic

Indeterminate GlobeNewswire
Verano Founder and Chief Executive Officer George Archos Celebrates Historic Announcement Confirming Cannabis Rescheduling to Schedule III
Apr. 23, 2026

Verano Founder and Chief Executive Officer George Archos Celebrates Historic Announcement Confirming Cannabis Rescheduling to Schedule III

Indeterminate GlobeNewswire
Jushi Holdings Inc. Applauds President Trump and Administration for Delivering on Cannabis Rescheduling to Schedule III under the Controlled Substances Act
Apr. 23, 2026

Jushi Holdings Inc. Applauds President Trump and Administration for Delivering on Cannabis Rescheduling to Schedule III under the Controlled Substances Act

Indeterminate GlobeNewswire
Lumina Therapy Alliance Expands Silicon Valley Presence with Addition of Wise Mind Institute in Redwood City, CA
Apr. 23, 2026

Lumina Therapy Alliance Expands Silicon Valley Presence with Addition of Wise Mind Institute in Redwood City, CA

Indeterminate GlobeNewswire
InnoCare Releases 2026 Q1 Results: Strong Revenue Growth and Sustained Profitability
Apr. 23, 2026

InnoCare Releases 2026 Q1 Results: Strong Revenue Growth and Sustained Profitability

Indeterminate GlobeNewswire
Women Are Ditching Generic Diets for Cycle-Based Wellness – This Cycle Diet App Review Explains Why
Apr. 23, 2026

Women Are Ditching Generic Diets for Cycle-Based Wellness – This Cycle Diet App Review Explains Why

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions